HERCULES, CA -- (MARKET WIRE) -- November 02, 2006 -- Bio-Rad Laboratories, Inc. (AMEX: BIO) (AMEX: BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced financial results today for the third quarter ended September 30, 2006. Third-quarter revenues from continuing operations were $304.8 million, up 7.6% compared to $283.2 million reported for the third quarter of 2005. On a currency-neutral basis, revenues increased 5.1% compared to the same period last year. This growth was driven by solid sales across product areas in both the Life Science and Clinical Diagnostics segments. Third-quarter income from continuing operations was $23.2 million compared to $16.2 million during the third quarter last year. The increase in net income included a pre-tax investment gain of $4.7 million realized during the quarter. Third-quarter gross margin from continuing operations was 54.7% compared to 55.4% in the same period last year.
